KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,891,281 | +16.4% | 4,374,044 | +35.1% | 0.88% | +20.2% |
| Q2 2023 | $34,258,040 | +17.5% | 3,238,000 | +35.9% | 0.73% | +12.5% |
| Q1 2023 | $29,144,090 | -1.5% | 2,383,000 | 0.0% | 0.65% | +6.2% |
| Q4 2022 | $29,573,030 | -2.4% | 2,383,000 | +7.4% | 0.61% | +1.5% |
| Q3 2022 | $30,313,000 | -37.0% | 2,219,128 | -15.5% | 0.60% | -39.3% |
| Q2 2022 | $48,153,000 | -32.2% | 2,627,000 | -40.5% | 0.99% | -37.5% |
| Q1 2022 | $71,015,000 | +44.4% | 4,416,361 | +25.7% | 1.59% | +53.9% |
| Q4 2021 | $49,193,000 | +13.4% | 3,513,756 | +51.8% | 1.03% | +22.0% |
| Q3 2021 | $43,368,000 | +15.9% | 2,315,417 | +29.1% | 0.85% | +27.4% |
| Q2 2021 | $37,405,000 | – | 1,794,000 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |